Ongoing research on PALB2 aims to better understand its role in cancer development and to develop targeted therapies. Researchers are investigating how PALB2 interacts with other proteins in the DNA repair pathway and how these interactions can be exploited for therapeutic purposes. Clinical trials are also underway to evaluate the efficacy of existing and new chemotherapeutic agents in patients with PALB2-related cancers.
